Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy.
Parikh PM, Vaid A, Advani SH, Digumarti R, Madhavan J, Nag S, Bapna A, Sekhon JS, Patil S, Ismail PM, Wang Y, Varadhachary A, Zhu J, Malik R. Parikh PM, et al. Among authors: sekhon js. J Clin Oncol. 2011 Nov 1;29(31):4129-36. doi: 10.1200/JCO.2010.34.4127. Epub 2011 Oct 3. J Clin Oncol. 2011. PMID: 21969509 Clinical Trial.
A multicenter phase II randomized study of Cremophor-free polymeric nanoparticle formulation of paclitaxel in women with locally advanced and/or metastatic breast cancer after failure of anthracycline.
Ranade AA, Bapsy PP, Nag S, Raghunadharao D, Raina V, Advani SH, Patil S, Maru A, Gangadharan VP, Goswami C, Sekhon JS, Sambasivaiah K, Parikh P, Bakshi A, Mohapatra R. Ranade AA, et al. Among authors: sekhon js. Asia Pac J Clin Oncol. 2013 Jun;9(2):176-81. doi: 10.1111/ajco.12035. Epub 2012 Nov 26. Asia Pac J Clin Oncol. 2013. PMID: 23176568 Clinical Trial.
Management of primary and metastatic triple negative breast cancer: perceptions of oncologists from India.
Parikh PM, Gupta S, Parikh B, Smruti BK, Issrani J, Topiwala S, Goswami C, Bhattacharya GS, Sen T, Sekhon JS, Malhotra H, Nag S, Chacko RT, Govind KB, Raja T, Vaid AK, Doval DC, Gupta S, Das PK. Parikh PM, et al. Among authors: sekhon js. Indian J Cancer. 2011 Apr-Jun;48(2):158-64. doi: 10.4103/0019-509X.82874. Indian J Cancer. 2011. PMID: 21768659 Free article.
Chemotherapy in biliary tract carcinomas: results in India.
Doval DC, Sekhon JS, Gupta SK, Gupta S, Awasthy BS. Doval DC, et al. Among authors: sekhon js. Semin Oncol. 2002 Dec;29(6 Suppl 20):46-50. doi: 10.1053/sonc.2002.37375. Semin Oncol. 2002. PMID: 12577233 Review.
Practical consensus recommendations for gestational breast cancer.
Sekhon JS, Naik N, Bansal P, Bansal I, Dhull A, Goel A, Ramachandran CS, Shinde S, Aggarwal S, Parikh PM. Sekhon JS, et al. South Asian J Cancer. 2018 Apr-Jun;7(2):115-117. doi: 10.4103/sajc.sajc_115_18. South Asian J Cancer. 2018. PMID: 29721476 Free PMC article.
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.
Kuse ER, Chetchotisakd P, da Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, Sekhon JS, Freire A, Ramasubramanian V, Demeyer I, Nucci M, Leelarasamee A, Jacobs F, Decruyenaere J, Pittet D, Ullmann AJ, Ostrosky-Zeichner L, Lortholary O, Koblinger S, Diekmann-Berndt H, Cornely OA; Micafungin Invasive Candidiasis Working Group. Kuse ER, et al. Among authors: sekhon js. Lancet. 2007 May 5;369(9572):1519-1527. doi: 10.1016/S0140-6736(07)60605-9. Lancet. 2007. PMID: 17482982 Clinical Trial.
38 results